Notably, increasing NO production with statins or using DPP4 inhibitor ,broadly used as hypoglycemic drugs for treatment of type 2 diabetes mellitus, might mitigate CAVD. The gene discussed is DPP4; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.